Did you see in the latest filing that they were only allotting $50,000 this year for imaging? That doesn't make alot of sense to me. However, I could invision a world where you treated early stage cancer using recaf monitoring and recaf based chemo delivery without having to know where the cancer is at. As long as you got your recaf level to come back down, i.e. cancer cured, why is it important to know where it was?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.